The use of frozen section and immunohistochemistry for sentinel lymph node biopsy in breast cancer

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Intraoperative pathologic evaluation of the sentinel lymph node (SLN) may guide immediate (synchronous) completion axillary lymph node dissection (ALND) for up to two-thirds of patients with nodal disease for breast cancer. The false-negative rates average one-third of cases, and one must be aware of false-positive results as this would result in unnecessary and morbid completion ALND. Currently, the use of immunohistochemistry (IHC) is controversial. There is no question that cytokeratin staining improves the sensitivity; however, there is no evidence that any of these "positive" cells are clinically significant and warrant therapy. Prospective randomized trials will be necessary to confirm or debunk the hypothesis that "sub- micrometastatic" disease has clinical significance.

Original languageEnglish (US)
Pages (from-to)414-419
Number of pages6
JournalAmerican Surgeon
Volume70
Issue number5
StatePublished - Dec 1 2004

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'The use of frozen section and immunohistochemistry for sentinel lymph node biopsy in breast cancer'. Together they form a unique fingerprint.

  • Cite this